Endometriosis and Pain Treatment by Intraoperative Administration of Low-dose Ketamine
Endometriosis and Pain Treatment by Intraoperative Administration of Low-dose Ketamine A Single-Centre, Prospective, Randomized, Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Endometriosis affects 10% of women of childbearing age and 25% - 50% of infertile women worldwide. Although most patients with endometriosis are completely asymptomatic, there are still a significant proportion of patients whose quality of life is impaired by the disease, resulting in chronic pelvic pain.
Hysterectomy is the most common surgical procedure performed in nonpregnant women when conservative strategies are ineffective. However, there is a poor correlation between objective findings of significant endometriosis and pain severity. Women with endometriosis are at a four-fold greater risk of long-term opioid use than those without endometriosis. Approximately 30% of women who undergo surgery for endometriosis report persistent pain after the surgical removal of the lesion(s). In addition to surgical trauma, other predisposing factors can influence the recovery or progression of chronic diseases, which should be considered when selecting perioperative treatment. Furthermore, studies have shown that in many surgical procedures, incision size and degree of tissue trauma are poorly related to postoperative pain intensity, depending on the pain treatment. After surgery, postoperative pain may be severe overall but usually resolves within the first day of surgery with a Numeric Rating Scale (NRS) pain score ≤ 4. Pain from laparoscopic endometriosis operation includes incisional pain, which may also be severe initially but subsides within the first half of the day; visceral pain that takes longer to resolve (up to a day); and shoulder pain (e.g., shoulder tip pain) that is milder. However, approximately 80% of women develop this condition after gynecologic laparoscopy procedures, which usually disappears within 24 hours and may last for several days. The typical duration of opioid rescue medication use is approximately four days. They should not cause discomfort or limit postoperative recovery.
Although the cause of endometriosis is not yet fully understood, chronic inflammation(s) and increased menstrual bleeding often leads to iron deficiency and even anemia. Iron deficiency anemia is the most common form of anemia, accounting for 50%. In 2019, the prevalence of girls and women of childbearing age (15 - 49 years) with anemia worldwide averaged 30%. For Switzerland, iron deficiency anemia is reported at 11.2 % and is well below the global average. Since iron and its deficiency play an important role in the pathogenesis of endometriosis and possibly also maintain it, it does not surprise that endometriosis patients have an increased risk of iron deficiency or anemia.These patients with a latent or manifest iron deficiency also complain of pain. Up to now, there are only indications that iron could play a role in the proinflammatory pain transmission pathways in endometriosis and could probably maintain and trigger chronic pain. As with nonsurgical chronic pain, psychological and social factors have an important impact that may persist for months or years after surgery. Suboptimal treatment of acute pain has many negative consequences including increased morbidity, impaired physical function and quality of life, slower recovery, prolonged opioid use during and after hospitalization, and increased care costs. Furthermore, in a significant proportion of patients, early postoperative pain appears to trigger pain that may persist for several months. Specifically, younger age, non-white race, lower education, history of sleep disorders, current smoking and alcohol use, high preoperative fibromyalgia screening scores, and high anxiety levels were associated with higher pain severity and excessive pain and may be underlying determinants. Also previous opioid consumption contributes to persistent postoperative pain. As pain is both a sensory and an emotional experience, psychological factors such as mood, disability, and pain coping (e.g., pain self-efficacy and pain catastrophizing) play an important role in this setting. Therefore, patients, particularly those with a predisposition or known tendency for depression, anxiety, or catastrophic symptoms, are at a high risk of developing chronic postsurgical pain. However, in some patients, acute postoperative pain persists beyond the tissue-healing period and develops into a chronic pain state. Approximately 10% of the patients undergoing surgery and 30% of those with endometriosis experience chronic pain. Patients, who have already taken preoperative painkillers or have significantly excessive postoperative analgesic consumption are at a risk of developing chronic pain. Nevertheless, opioids are often overused, particularly during the post discharge period. Even today, acute pain management in the setting of trauma, exacerbation of chronic painful conditions, and postsurgical pain, particularly in patients who are opioid-tolerant remains a challenge in the perioperative setting. In this context, ketamine can be used, generally at subanesthetic doses. However, some patients reported severe debilitating side effects of ketamine administration that did not tolerate higher ketamine doses, an adequate balance of analgesia, and adverse effects in continuous low-dose ketamine in the range of 0.1 - 0.5 mg·kg-1·h-1 was described as sufficient.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Contact
Study Contact
- Name: Christian Vetter, MD
- Phone Number: +416343776
- Email: christian.vetter@insel.ch
Study Contact Backup
- Name: Gianluca Comazzi, MD
- Phone Number: +416322111
- Email: gianluca.comazzi@insel.ch
Study Locations
-
-
-
Bern, Switzerland, 3010
- Recruiting
- Inselspital Bern
-
Contact:
- Christian cv Vetter, MD
- Phone Number: +41 632 52 83
- Email: christian.vetter@freenet.de
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients undergoing surgery for endometriosis operation requiring general anaesthesia at the Inselspital, Bern University Hospital, University of Bern, Department of gynaecology and obstetrics.
- Age ≥ 18 years
- American Society of Anesthesiologist (ASA) physical status 1-3
- Patients with known or suspected endometriosis
- Written informed consent.
Exclusion Criteria:
- Age < 18 years
- ASA physical status ≥4
- Higher-grade atrioventricular block without pacemaker
- Severe hypovolemia or bradycardia
- Uncontrolled hyper- or hypotension
- Liver disease
- Known malignant hyperthermia
- Cardiovascular instability or severe heart failure (New York Heart Association classification (NYHA) > III)
- Myocardial infarction during the last 30 days prior to surgery
- Increased intracranial or increased intraocular pressure
- Limited peripheral autonomic activity, hypersensitivity to ketamine or propofol or its components
- Pregnancy
- Rejection or lack of consent of the patient or relatives
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Group Ketamine
Standard anaesthesia with propofol and administration of ketamine.
|
Low-dose administration of ketamine during laparoscopic surgery
Control group
|
|
Other: Group Control
Standard anaesthesia with propofol.
|
Control group
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total opioids prescribed and consumed during hospitalization for endometriosis.
Time Frame: During hospitalisation, expected to be on average 2-5 days
|
The primary study outcome is the total opioids consumed during hospitalisation (converted in oral morphine equivalents)
|
During hospitalisation, expected to be on average 2-5 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Daily pain severity during hospitalization
Time Frame: During hospitalisation, expected to be on average 2-5 days
|
Pain score, measured by questionaire, scale from 0 to 10, with higher values corresponding to higher pain level
|
During hospitalisation, expected to be on average 2-5 days
|
|
Postoperative complications
Time Frame: During hospitalisation, expected to be on average 2-5 days
|
Number of patients with nausea, vomiting or dizziness
|
During hospitalisation, expected to be on average 2-5 days
|
|
Patient wellbeing
Time Frame: 30 days to 6 months after surgery
|
Measured by questionnaire
|
30 days to 6 months after surgery
|
|
Preoperative iron status
Time Frame: Preoperatively (expected to be on average 2-5 days prior to surgery)
|
Iron status will be classified as normal, latent iron deficiency, or manifest iron deficiency based on laboratory values (e.g., hemoglobin, ferritin, transferrin saturation).
Evaluation of manifest or latent iron deficiency, measured by laboratory testing.
The scale typically ranges from 0 to over 300 µg/L in clinical practice, but the diagnostic focus is on lower values.
For adults, a ferritin concentration below 10-15 µg/L is generally considered indicative of iron deficiency.
Higher values indicate better iron stores, but values above the upper reference limit may suggest iron overload or inflammation.
|
Preoperatively (expected to be on average 2-5 days prior to surgery)
|
|
Pain score
Time Frame: During hospitalisation, expected to be on average 2-5 days
|
Assessed using the Numeric Rating Scale (NRS), which ranges from 0 (no pain) to 10 (worst imaginable pain).
Higher scores indicate worse pain.
NRS score (0-10)
|
During hospitalisation, expected to be on average 2-5 days
|
|
Total postoperative analgesic consumption before discharge
Time Frame: During hospitalisation, expected to be on average 2-5 days
|
The total amount of analgesics consumed postoperatively, converted to intravenous morphine equivalents using standard conversion tables.
Higher values indicate greater analgesic requirement.
Milligrams of intravenous morphine equivalent (mg IV MEQ)
|
During hospitalisation, expected to be on average 2-5 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Christian Vetter, MD, Dep. of Anaesthesiology and Pain Medicine, Inselsptial Bern
Publications and helpful links
General Publications
- Gerbershagen HJ, Aduckathil S, van Wijck AJ, Peelen LM, Kalkman CJ, Meissner W. Pain intensity on the first day after surgery: a prospective cohort study comparing 179 surgical procedures. Anesthesiology. 2013 Apr;118(4):934-44. doi: 10.1097/ALN.0b013e31828866b3.
- Abbott J, Hawe J, Hunter D, Holmes M, Finn P, Garry R. Laparoscopic excision of endometriosis: a randomized, placebo-controlled trial. Fertil Steril. 2004 Oct;82(4):878-84. doi: 10.1016/j.fertnstert.2004.03.046.
- Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016 Feb 27;387(10021):907-16. doi: 10.1016/S0140-6736(15)60865-0. Epub 2015 Aug 24.
- Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011 Jun;38(6):1113-22. doi: 10.3899/jrheum.100594. Epub 2011 Feb 1.
- Schwenk ES, Viscusi ER, Buvanendran A, Hurley RW, Wasan AD, Narouze S, Bhatia A, Davis FN, Hooten WM, Cohen SP. Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018 Jul;43(5):456-466. doi: 10.1097/AAP.0000000000000806.
- Glare P, Aubrey KR, Myles PS. Transition from acute to chronic pain after surgery. Lancet. 2019 Apr 13;393(10180):1537-1546. doi: 10.1016/S0140-6736(19)30352-6.
- Lirk P, Thiry J, Bonnet MP, Joshi GP, Bonnet F; PROSPECT Working Group. Pain management after laparoscopic hysterectomy: systematic review of literature and PROSPECT recommendations. Reg Anesth Pain Med. 2019 Apr;44(4):425-436. doi: 10.1136/rapm-2018-100024. Epub 2019 Feb 3.
- Kanellos P, Nirgianakis K, Siegenthaler F, Vetter C, Mueller MD, Imboden S. Postoperative Pain Is Driven by Preoperative Pain, Not by Endometriosis. J Clin Med. 2021 Oct 15;10(20):4727. doi: 10.3390/jcm10204727.
- Chiuve SE, Kilpatrick RD, Hornstein MD, Petruski-Ivleva N, Wegrzyn LR, Dabrowski EC, Velentgas P, Snabes MC, Bateman BT. Chronic opioid use and complication risks in women with endometriosis: A cohort study in US administrative claims. Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):787-796. doi: 10.1002/pds.5209. Epub 2021 Mar 16.
- Cappellini MD, Comin-Colet J, de Francisco A, Dignass A, Doehner W, Lam CS, Macdougall IC, Rogler G, Camaschella C, Kadir R, Kassebaum NJ, Spahn DR, Taher AT, Musallam KM; IRON CORE Group. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. Am J Hematol. 2017 Oct;92(10):1068-1078. doi: 10.1002/ajh.24820. Epub 2017 Jul 7.
- World Health Organization. (2021). Anaemia in women and children. The Global Health Observatory. Retrieved July 4, 2022, from. https://www.who.int/data/gho/data/themes/topics/anaemia_ in_women_and_children
- Gete DG, Doust J, Mortlock S, Montgomery G, Mishra GD. Risk of Iron Deficiency in Women With Endometriosis: A Population-Based Prospective Cohort Study. Womens Health Issues. 2024 May-Jun;34(3):317-324. doi: 10.1016/j.whi.2024.03.004. Epub 2024 Apr 24.
- Maddern J, Grundy L, Castro J, Brierley SM. Pain in Endometriosis. Front Cell Neurosci. 2020 Oct 6;14:590823. doi: 10.3389/fncel.2020.590823. eCollection 2020.
- Wyatt J, Fernando SM, Powell SG, Hill CJ, Arshad I, Probert C, Ahmed S, Hapangama DK. The role of iron in the pathogenesis of endometriosis: a systematic review. Hum Reprod Open. 2023 Jul 27;2023(3):hoad033. doi: 10.1093/hropen/hoad033. eCollection 2023.
- Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, Bohnert ASB, Kheterpal S, Nallamothu BK. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA Surg. 2017 Jun 21;152(6):e170504. doi: 10.1001/jamasurg.2017.0504. Epub 2017 Jun 21.
- Shirvalkar P, Prosky J, Chin G, Ahmadipour P, Sani OG, Desai M, Schmitgen A, Dawes H, Shanechi MM, Starr PA, Chang EF. First-in-human prediction of chronic pain state using intracranial neural biomarkers. Nat Neurosci. 2023 Jun;26(6):1090-1099. doi: 10.1038/s41593-023-01338-z. Epub 2023 May 22.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urogenital Diseases
- Genital Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Genital Diseases, Female
- Endometriosis
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Anesthetics
- Central Nervous System Depressants
- Sensory System Agents
- Analgesics
- Neurotransmitter Agents
- Hypnotics and Sedatives
- Anesthetics, Intravenous
- Anesthetics, General
- Excitatory Amino Acid Agents
- Anesthetics, Dissociative
- Excitatory Amino Acid Antagonists
- Propofol
- Ketamine
Other Study ID Numbers
Other Study ID Numbers
- 2024-01677
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometriosis
-
NCT04296760CompletedEndometriosis | Endometriosis, Rectum | Endometriosis of Vagina | Endometriosis Rectovaginal Septum | Endometriosis Pelvic | Endometriosis of Colon
-
NCT03481842WithdrawnSafety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis (ELTA)Endometriosis | Endometriosis Ovary | Endometriosis, Rectum | Endometriosis Externa
-
NCT04338035CompletedEndometriosis | Bowel Endometriosis | Endometriosis, Rectum | Endometriosis Colon
-
NCT05527002CompletedEndometriosis | Endometriosis-related Pain | Endometriosis Thoracic | Endometriosis of Lung | Endometriosis of Pleura
-
NCT03532074UnknownBowel Endometriosis | Endometriosis, Rectum
-
NCT04295343CompletedEndometriosis, Rectum | Endometriosis, Sigmoid
-
NCT04401592Not yet recruitingEndometriosis | Endometriosis Ovary | Endometriosis Rectovaginal Septum
-
NCT03332004CompletedPelvic Endometriosis | Endometriosis Outside Pelvis
-
NCT07517055Not yet recruitingEndometriosis | Endometriosis, Rectum | Endometriosis of Colon | Endometriosis; Bowel
-
NCT04339946Active, not recruitingEndometriosis, Rectum | Endometriosis of Colon
Clinical Trials on Ketamine
-
NCT07401914Active, not recruitingGastrointestinal Endoscopy | Procedural Sedation
-
NCT07536633Completed
-
NCT07247006Not yet recruitingChronic Pain | Treatment Resistant Depression (TRD)
-
NCT07450430Not yet recruitingSickle Cell Disease | Sickle Cell Crisis
-
NCT05907213CompletedPain, Postoperative | Depression, Postpartum
-
NCT07429916RecruitingPain Management | Laparascopic Sleeve Gastrectomy
-
NCT07250867Not yet recruiting